Literature DB >> 3661823

Gastric dysplasia. A histological follow-up study.

E P Saraga1, D Gardiol, J Costa.   

Abstract

To evaluate the clinical and biological significance of gastric dysplasia, we reviewed the histology of all available specimens of gastric mucosa in 85 patients in whom dysplasia had been previously diagnosed. The initial diagnosis of dysplasia was mild (Dy I) in 23 cases, moderate (Dy II) in 41 cases, and severe (Dy III) in 21 cases. The length of follow-up varied from 3 months to 11 years, with an average of 42 months. The follow-up of cases with Dy I and Dy II suggests that both lesions progress slowly and in most instances will remain stable or regress. In 18 cases, a carcinoma was found--17 in the group of Dy III and one in the group of Dy II. Of the 18 carcinomas, nine were at an early stage. Our data suggest that severe dysplasia is a reliable marker of high risk of gastric cancer and represents a strong indication for a gastrectomy.

Entities:  

Mesh:

Year:  1987        PMID: 3661823

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

Review 1.  Gastric epithelial dysplasia.

Authors:  G Y Lauwers; R H Riddell
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

2.  Gastric epithelial dysplasia.

Authors:  F Farinati; M Rugge; F Valiante; R Baffa; F Di Mario; R Naccarato
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

3.  Chromoendoscopic mucosal resection of a gastric dysplasia.

Authors:  David Costa-Navarro; Israel Oliver-García; Francisco Javier Lacueva-Gómez; Javier Sola-Vera; Eva Girona-Torres; Encarna Andrada-Becerra; Ana Fernández-Frías; Rafael Calpena-Rico
Journal:  Clin Transl Oncol       Date:  2005 Jan-Feb       Impact factor: 3.405

4.  Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study.

Authors:  A Kokkola; R Haapiainen; F Laxén; P Puolakkainen; E Kivilaakso; J Virtamo; P Sipponen
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

5.  Treatment strategy for gastric non-invasive intraepithelial neoplasia diagnosed by endoscopic biopsy.

Authors:  Tsutomu Nishida; Shusaku Tsutsui; Motohiko Kato; Takuya Inoue; Shunsuke Yamamoto; Yoshito Hayashi; Tomofumi Akasaka; Takuya Yamada; Shinichiro Shinzaki; Hideki Iijima; Masahiko Tsujii; Tetsuo Takehara
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

6.  High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma.

Authors:  M Lansdown; P Quirke; M F Dixon; A T Axon; D Johnston
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

7.  Detection of c-Ki-ras oncogene mutation in gastric adenomas with formalin-fixed, paraffin-embedded biopsy materials.

Authors:  C Tsuchiya; S Ohshima; M Takahama
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

8.  Comparative study of Western and Japanese criteria for biopsy-based diagnosis of gastric epithelial neoplasia.

Authors:  Masao Yoshida; Tadakazu Shimoda; Kimihide Kusafuka; Takashi Sugino; Takashi Nakajima; Hiroyuki Ono
Journal:  Gastric Cancer       Date:  2014-05-01       Impact factor: 7.370

9.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

10.  The long term outcome of gastric non-invasive neoplasia.

Authors:  M Rugge; M Cassaro; F Di Mario; G Leo; G Leandro; V M Russo; G Pennelli; F Farinati
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.